COVID-19 vaccine: additional contract with Pfizer secures vaccine supply for 2022 and 2023
Bern, 25.8.2021 - The federal government has signed another contract with biopharma firm Pfizer. This will ensure access to a sufficient supply of mRNA vaccine for the Swiss population for the next two years. The new contract provides for the delivery of 7 million doses in both 2022 and 2023, with an option of an additional 7 million doses each year. This is subject to a modified Pfizer/BioNTech vaccine being authorised for use by Swissmedic.